During the past decade, Policlinico Casilino conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 6 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Policlinico Casilino" #1 sponsor was "Policlinico Casilino ASL RMB" with 7 trials, followed by "Boston Scientific Corporation" with 6 trials sponsored, "Abbott Medical Devices" with 4 trials sponsored, "Biotronik SE & Co. KG" with 4 trials sponsored and "MicroPort CRM" with 4 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Policlinico Casilino" #1 collaborator was "IRCCS San Raffaele" with 3 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Associazione Nazionale Medici Cardiologi Ospedalieri" with 1 trials as a collaborator, "Azienda Ospedaliero-Universitaria di Modena" with 1 trials as a collaborator and "Biotronik Italia" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Policlinico Casilino" are "Heart Failure" (6 trials), "Coronary Artery Disease" (4 trials), "Atrial Fibrillation" (3 trials), "Bradycardia" (2 trials) and "Chronic Kidney Disease Requiring Chronic Dialysis" (2 trials). Many other conditions were trialed in "Policlinico Casilino" in a lesser frequency.

Most popular intervention types in "Policlinico Casilino" are "Device" (19 trials), "Drug" (7 trials), "Procedure" (5 trials), "Behavioral" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Edoxaban" (2 trials), "Evolocumab" (2 trials), "Ezetimibe" (2 trials), "Placebo" (2 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Policlinico Casilino" are 34 trials for "All" genders.

Currently, there are NaN active trials in "Policlinico Casilino". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 15 completed trials in Policlinico Casilino, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Policlinico Casilino, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 13 trials that are defined as “Not Applicable".

Policlinico Casilino has several departments that took part in Clinical trials: "Policlinico Casilino - U.O. Cardiologia" - 6 trials